| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.422 | 25.322 | 0 | 56.830 | 44.423 | 43.240 | 54.810 | 57.744 | 79.065 | - |
| Total Income - EUR | 49.427 | 25.340 | 0 | 56.853 | 44.427 | 44.259 | 54.811 | 57.744 | 79.090 | - |
| Total Expenses - EUR | 41.512 | 19.939 | 0 | 31.570 | 38.004 | 27.958 | 46.129 | 52.710 | 71.968 | - |
| Gross Profit/Loss - EUR | 7.915 | 5.400 | 0 | 25.283 | 6.423 | 16.300 | 8.681 | 5.034 | 7.123 | - |
| Net Profit/Loss - EUR | 6.432 | 5.147 | 0 | 24.715 | 5.978 | 15.857 | 8.164 | 3.677 | 4.750 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | - |
Check the financial reports for the company - Dumipet Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 13.519 | 13.257 | 15.182 | 14.845 | 14.891 | 14.846 | - |
| Current Assets | 139 | 15.433 | 0 | 25.829 | 24.543 | 41.577 | 55.497 | 38.198 | 60.059 | - |
| Inventories | 0 | 11.591 | 0 | 14.462 | 6.953 | 19.251 | 47.563 | 15.490 | 45.761 | - |
| Receivables | 22 | 3.804 | 0 | 8.936 | 17.533 | 4.098 | 4.007 | 19.626 | 4.326 | - |
| Cash | 117 | 38 | 0 | 2.431 | 56 | 18.227 | 3.926 | 3.082 | 9.971 | - |
| Shareholders Funds | 6.477 | 11.558 | 0 | 31.720 | 37.084 | 52.238 | 59.244 | 63.105 | 67.663 | - |
| Social Capital | 45 | 45 | 0 | 43 | 42 | 41 | 0 | 41 | 40 | - |
| Debts | -6.338 | 3.875 | 0 | 7.628 | 715 | 4.520 | 11.098 | 0 | 7.242 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4613 - 4613" | |||||||||
| CAEN Financial Year |
4613
|
|||||||||
Comments - Dumipet Intermed Srl